<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39189205</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>27</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>04</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2076-3271</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>3</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>18</Day></PubDate></JournalIssue><Title>Medical sciences (Basel, Switzerland)</Title><ISOAbbreviation>Med Sci (Basel)</ISOAbbreviation></Journal><ArticleTitle>Antibiotic Resistance &amp; Extended-Spectrum ß-Lactamase Production in Clinical and Non-Clinical Isolates in Tabuk.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">42</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/medsci12030042</ELocationID><Abstract><AbstractText>The increasing prevalence of antibiotic resistance, driven by the production of extended-spectrum beta-lactamases (ESBLs), presents a critical challenge to current medical treatments, particularly in clinical settings. Understanding the distribution and frequency of ESBL-producing bacteria is essential for developing effective control strategies. This study investigated the antibiotic resistance and extended-spectrum beta-lactamase (ESBL) production in bacterial isolates in clinical and non-clinical (food) specimens in Tabuk, KSA. A total of 57 bacterial isolates were analysed, with <i>E. coli</i> and <i>Pseudomonas</i> sp. being the most prevalent. High resistance rates were observed, particularly against third-generation cephalosporins in clinical isolates. ESBL screening revealed a significant prevalence in clinical samples (58.3%), with <i>E. coli</i> showing the highest positivity. Conversely, only a low percentage of food isolates were ESBL positive. Molecular analysis confirmed the presence of various ESBL genes, with <i>bla<sub>CTX</sub></i><sub>-M</sub> being the most frequent, predominantly found in clinical isolates. This study highlights the concerning levels of antibiotic resistance and ESBL production in the region, emphasising the need for effective infection control measures and prudent antibiotic use.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Alanazi</LastName><ForeName>Badriah</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Mathematics, Faculty of Science, University of Tabuk, Tabuk 47512, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muhiuddin</LastName><ForeName>Ghulam</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-5596-5841</Identifier><AffiliationInfo><Affiliation>Department of Mathematics, Faculty of Science, University of Tabuk, Tabuk 47512, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Albalawi</LastName><ForeName>Yazeed</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Obstetrics &amp; Gynecology, Faculty of Medicine, University of Tabuk, Tabuk 47512, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alhazmi</LastName><ForeName>Khalid</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Pathology, Faculty of Medicine, University of Tabuk, Tabuk 47512, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alzahrani</LastName><ForeName>Othman</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0002-2726-0473</Identifier><AffiliationInfo><Affiliation>Department of Biology, Faculty of Science, University of Tabuk, Tabuk 47512, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alamri</LastName><ForeName>Marai</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Surgery, Faculty of Medicine, University of Tabuk, Tabuk 47512, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alshadfan</LastName><ForeName>Hisham</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-6827-939X</Identifier><AffiliationInfo><Affiliation>Department of Clinical Biochemistry, Faculty of Medicine, University of Tabuk, Tabuk 47512, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zubair</LastName><ForeName>Mohammad</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-5787-7845</Identifier><AffiliationInfo><Affiliation>Department of Medical Microbiology, Faculty of Medicine, University of Tabuk, Tabuk 47512, Saudi Arabia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>Research no.0062-1444-S</GrantID><Agency>The authors extend their appreciation to the Deanship of Research and Graduate Studies at the University of Tabuk for funding this work</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Med Sci (Basel)</MedlineTA><NlmUniqueID>101629322</NlmUniqueID><ISSNLinking>2076-3271</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.5.2.6</RegistryNumber><NameOfSubstance UI="D001618">beta-Lactamases</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001618" MajorTopicYN="Y">beta-Lactamases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008826" MajorTopicYN="N">Microbial Sensitivity Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004926" MajorTopicYN="N">Escherichia coli</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011549" MajorTopicYN="N">Pseudomonas</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D024881" MajorTopicYN="N">Drug Resistance, Bacterial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005516" MajorTopicYN="N">Food Microbiology</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AmpC</Keyword><Keyword MajorTopicYN="N">CTX-M</Keyword><Keyword MajorTopicYN="N">ESBL</Keyword><Keyword MajorTopicYN="N">SHV</Keyword><Keyword MajorTopicYN="N">TEM</Keyword><Keyword MajorTopicYN="N">clinical</Keyword><Keyword MajorTopicYN="N">non-clinical</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>27</Day><Hour>9</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>27</Day><Hour>9</Hour><Minute>49</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>27</Day><Hour>5</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39189205</ArticleId><ArticleId IdType="pmc">PMC11348262</ArticleId><ArticleId IdType="doi">10.3390/medsci12030042</ArticleId><ArticleId IdType="pii">medsci12030042</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Murray C.J., Ikuta K.S., Sharara F., Swetschinski L., Aguilar G.R., Gray A., Han C., Bisignano C., Rao P., Wool E., et al. Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis. Lancet. 2022;399:629–655. doi: 10.1016/S0140-6736(21)02724-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)02724-0</ArticleId><ArticleId IdType="pmc">PMC8841637</ArticleId><ArticleId IdType="pubmed">35065702</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaikh S., Fatima J., Shakil S., Rizvi SM D., Kamal M.A. Antibiotic resistance and extended spectrum beta-lactamases: Types, epidemiology and treatment. Saudi J. Biol. Sci. 2015;22:90–101. doi: 10.1016/j.sjbs.2014.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sjbs.2014.08.002</ArticleId><ArticleId IdType="pmc">PMC4281622</ArticleId><ArticleId IdType="pubmed">25561890</ArticleId></ArticleIdList></Reference><Reference><Citation>Alqahtani T.M.T., Alelyani A.A., Yousuf M.M.M., Alhujayri W.M.K., Husain F.M., Zubair M. Study of Plasmid-Mediated Extended-Spectrum Beta-Lactamase-Producing Clinical Strains of Enterobacteriaceae From Tabuk Region. Cureus. 2023;15:e40183. doi: 10.7759/cureus.40183.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.40183</ArticleId><ArticleId IdType="pmc">PMC10329841</ArticleId><ArticleId IdType="pubmed">37431354</ArticleId></ArticleIdList></Reference><Reference><Citation>Collee J.G., Miles R.S., Watt B. In: Mackie and McCartney Practical Microbiology. Collee J.G., Marmion B.P., Fraser A.G., Simmons A., editors. Churchill Livingstone; London, UK: 2014.</Citation></Reference><Reference><Citation>CLSI . Performance Standard for Antimicrobial Susceptibility Testing. Volume 27. CLSI; Wayne, PA, USA: 2016. p. M100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jcm.01934-17</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinical and Laboratory Standards Institute  . CLSI Supplement M100. CLSI; Wayne, PA, USA: 2020.  [(accessed on 14 August 2024)]. Performance Standards for Antimicrobial Susceptibility Testing: Seventeenth Informational Supplement. Available online:  https://clsi.org/standards/products/microbiology/documents/m100/</Citation></Reference><Reference><Citation>Shahid M., Malik A., Adil M., Jahan N., Malik R. Comparison of beta-lactamase genes in clinical and food bacterial isolates in India. J. Infect. Dev. Ctries. 2009;3:593–598. doi: 10.3855/jidc.550.</Citation><ArticleIdList><ArticleId IdType="doi">10.3855/jidc.550</ArticleId><ArticleId IdType="pubmed">19801801</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahid M., Ensor V.M., Hawkey P.M. Emergence and dissemination of Enterobacteriaceae with plasmid-mediated CMY-6 and CTX-M-15 beta-lactamases in a community in North-India. World J. Micribiol. Biotechniol. 2009;25:1439–1446. doi: 10.1007/s11274-009-0032-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11274-009-0032-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Ventola C.L. The antibiotic resistance crisis: Part 1: Causes and threats. Pharm. Ther. 2015;40:277–283.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4378521</ArticleId><ArticleId IdType="pubmed">25859123</ArticleId></ArticleIdList></Reference><Reference><Citation>Pitout J.D., Laupland K.B. Extended-spectrum β-lactamase-producing Enterobacteriaceae: An emerging public-health concern. Lancet Infect. Dis. 2008;8:159–166. doi: 10.1016/S1473-3099(08)70041-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(08)70041-0</ArticleId><ArticleId IdType="pubmed">18291338</ArticleId></ArticleIdList></Reference><Reference><Citation>Beuchat L.R., Ryu J. Produce handling and processing practices. Emerg. Infect. Dis. 1997;3:459–465. doi: 10.3201/eid0304.970407.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid0304.970407</ArticleId><ArticleId IdType="pmc">PMC2640071</ArticleId><ArticleId IdType="pubmed">9366597</ArticleId></ArticleIdList></Reference><Reference><Citation>Scallan E., Hoekstra R.M., Angulo F.J., Tauxe R.V., Widdowson M.A., Roy S.L., Griffin P.M. Foodborne illness acquired in the United States—Major pathogens. Emerg. Infect. Dis. 2011;17:7–15. doi: 10.3201/eid1701.P11101.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1701.P11101</ArticleId><ArticleId IdType="pmc">PMC3375761</ArticleId><ArticleId IdType="pubmed">21192848</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrido A., Atxaerandio R., Vergara A., Bustamante H., Ruiz J. Pseudomonas spp. in the milk environment: An emerging problem in the dairy industry. J. Dairy Sci. 2014;97:4060–4071.</Citation></Reference><Reference><Citation>Vincent J.L., Bihari D.J., Suter P.M., Bruining H.A., White J., Nicolas-Chanoin M.H. The prevalence of nosocomial infection in intensive care units in Europe. JAMA. 1995;274:639–644. doi: 10.1001/jama.1995.03530080055041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.1995.03530080055041</ArticleId><ArticleId IdType="pubmed">7637145</ArticleId></ArticleIdList></Reference><Reference><Citation>Richards M.J., Edwards J.R., Culver D.H., Gaynes R.P. Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit. Care Med. 2000;27:887–892. doi: 10.1097/00003246-199905000-00020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-199905000-00020</ArticleId><ArticleId IdType="pubmed">10362409</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobsen S.M., Stickler D.J., Mobley H.L., Shirtliff M.E. Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis. Clin. Microbiol. Rev. 2008;21:26–59. doi: 10.1128/CMR.00019-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.00019-07</ArticleId><ArticleId IdType="pmc">PMC2223845</ArticleId><ArticleId IdType="pubmed">18202436</ArticleId></ArticleIdList></Reference><Reference><Citation>Lynch M.F., Tauxe R.V., Hedberg W.C. The growing burden of foodborne outbreaks due to contaminated fresh produce: Risks and opportunities. Epidemiol. Infect. 2009;137:307–315. doi: 10.1017/S0950268808001969.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0950268808001969</ArticleId><ArticleId IdType="pubmed">19200406</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Boeckel T.P., Brower C., Gilbert M., Grenfell B.T., Levin S.A., Robinson T.P., Laxminarayan R. Global trends in antimicrobial use in animals. Proc. Natl. Acad. Sci. USA. 2015;112:5649–5654. doi: 10.1073/pnas.1503141112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1503141112</ArticleId><ArticleId IdType="pmc">PMC4426470</ArticleId><ArticleId IdType="pubmed">25792457</ArticleId></ArticleIdList></Reference><Reference><Citation>Nordmann P., Poirel L. Epidemiology and diagnostics of carbapenem resistance in Gram-negative bacteria. Clin. Infect. Dis. 2019;69:S521–S528. doi: 10.1093/cid/ciz824.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciz824</ArticleId><ArticleId IdType="pmc">PMC6853758</ArticleId><ArticleId IdType="pubmed">31724045</ArticleId></ArticleIdList></Reference><Reference><Citation>Paterson D.L., Bonomo R.A. Extended-spectrum β-lactamases: A clinical update. Clin. Microbiol. Rev. 2005;18:657–686. doi: 10.1128/CMR.18.4.657-686.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.18.4.657-686.2005</ArticleId><ArticleId IdType="pmc">PMC1265908</ArticleId><ArticleId IdType="pubmed">16223952</ArticleId></ArticleIdList></Reference><Reference><Citation>Laxminarayan R., Duse A., Wattal C., Zaidi A.K.M., Wertheim H.F.L., Sumpradit N., Vlieghe E., Hara G.L., Gould I.M., Goossens H., et al. Antibiotic resistance—The need for global solutions. Lancet Infect. Dis. 2013;13:1057–1098. doi: 10.1016/S1473-3099(13)70318-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(13)70318-9</ArticleId><ArticleId IdType="pubmed">24252483</ArticleId></ArticleIdList></Reference><Reference><Citation>Bassetti M., Peghin M., Vena A., Giacobbe D.R. Treatment of Infections Due to MDR Gram-Negative Bacteria. Front. Med. 2018;5:74. doi: 10.3389/fmed.2019.00074.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2019.00074</ArticleId><ArticleId IdType="pmc">PMC6477053</ArticleId><ArticleId IdType="pubmed">31041313</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan D.J., Okeke I.N., Laxminarayan R., Perencevich E.N., Weisenberg S. Non-prescription antimicrobial use worldwide: A systematic review. Lancet Infect. Dis. 2011;11:692–701. doi: 10.1016/S1473-3099(11)70054-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(11)70054-8</ArticleId><ArticleId IdType="pmc">PMC3543997</ArticleId><ArticleId IdType="pubmed">21659004</ArticleId></ArticleIdList></Reference><Reference><Citation>Zubair M., Mohammad I. Interrelationship of Extended Spectrum Beta-Lactamase Producers and Biofilm Formation among the Gram-Negative Bacteria from Tabuk, KSA. Open Access Maced. J. Med. Sci. 2023;11:15–22. doi: 10.3889/oamjms.2023.11101.</Citation><ArticleIdList><ArticleId IdType="doi">10.3889/oamjms.2023.11101</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Maary K.S., Abbass F.M., El-Ghany W.A., Ibrahim S.M. Prevalence and molecular characterization of ESBL-producing Enterobacteriaceae from different clinical samples in Saudi Arabia. Antibiotics. 2021;10:421. doi: 10.4103/0256-4947.55306.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0256-4947.55306</ArticleId><ArticleId IdType="pmc">PMC8069180</ArticleId><ArticleId IdType="pubmed">33920369</ArticleId></ArticleIdList></Reference><Reference><Citation>Colodner R., Rock W., Chazan B., Sakran W. Risk factors for developing extended-spectrum beta-lactamase-producing bacteria in non-hospitalized patients. Eur. J. Clin. Microbiol. Infect. Dis. 2004;3:163–167. doi: 10.1007/s10096-003-1084-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-003-1084-2</ArticleId><ArticleId IdType="pubmed">14986159</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Bulushi I.M., Poole S.E., Barlow R., Katouli M., Hart C.A. Antibiotic resistance of Escherichia coli and Listeria spp. isolated from fresh produce and ready-to-eat salads marketed in Saudi Arabia. Antibiotics. 2020;9:152. doi: 10.3390/antibiotics9030152.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antibiotics9030152</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Ensor V.M., Shahid M., Evans J.T., Hawkey P.M. Occurrence, Prevalence and Genetic Environment of CTX-M Beta-lactamase in Enterobacteriaceae from Indian Hospitals. J. Antimicrob. Chemother. 2006;58:1260–1263. doi: 10.1093/jac/dkl422.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jac/dkl422</ArticleId><ArticleId IdType="pubmed">17071956</ArticleId></ArticleIdList></Reference><Reference><Citation>Dioli C., Pappa O., Siatravani E., Bratakou S., Tatsiopoulos A., Giakkoupi P., Miriagou V., Beloukas A. Molecular Characterization and Prevalence of Antimicrobial-Resistant Escherichia coli Isolates Derived from Clinical Specimens and Environmental Habitats. Microorganisms. 2023;11:1399. doi: 10.3390/microorganisms11061399.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms11061399</ArticleId><ArticleId IdType="pmc">PMC10305429</ArticleId><ArticleId IdType="pubmed">37374900</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassan A.A., Al-Mousa H.A., Al-Zahrani I.A. Prevalence and characterization of antibiotic-resistant Enterobacteriaceae in retail seafood from Saudi Arabian markets. Antibiotic. 2021;10:752. doi: 10.3390/antibiotics10060752.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antibiotics10060752</ArticleId></ArticleIdList></Reference><Reference><Citation>Babiker A.M., Bukhari E.E., Hawsawi Z.A. Molecular characterization of extended-spectrum β-lactamase-producing Enterobacteriaceae in a tertiary care hospital in Saudi Arabia. J. Infect. Dev. Ctries. 2021;14:858–866. doi: 10.3855/jidc.3809.</Citation><ArticleIdList><ArticleId IdType="doi">10.3855/jidc.3809</ArticleId></ArticleIdList></Reference><Reference><Citation>Vahaboglu H., Budak F., Kasap M., Gacar G., Torol S., Karadenizli A., Kolayli F., Eroglu C. High prevalence of OXA-51-type class D beta-lactamases among ceftazidime-resistant clinical isolates of Acinetobacter spp.: Co-existence with OXA-58 in multiple centres. J. Antimicrob. Chemother. 2006;58:537–542. doi: 10.1093/jac/dkl273.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jac/dkl273</ArticleId><ArticleId IdType="pubmed">16816400</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>